key: cord-0766733-s0o1303u
authors: Dağıstanlı, Sevinç; Sönmez, Süleyman
title: Spleen infarct secondary to thrombus in COVID-19-related splenic vein: a case report
date: 2021-04-06
journal: Arab J Gastroenterol
DOI: 10.1016/j.ajg.2021.03.003
sha: eeb61fc6e4f7c12e51e3b454dd3b5483853dea39
doc_id: 766733
cord_uid: s0o1303u

Splanchnic venous thrombosis is a rare type of venous thromboembolism, and its actual incidence is still unknown. Splenic infarction develops due to splenic vein (SV) thrombosis. Patients with COVID-19 had a risk of thrombotic events, and the system affected at the highest level by coagulopathy is the respiratory system. The case presented here is splenic infarction that developed because of SV thrombosis, which is a rare form of venous thromboembolism.

it may happen in the abdominal vascular system.

-In a patient with COVID-19 with splenic infarction, complete obstruction of the splenic vein should be considered. 

On May 22, 2020, a 46-year-old woman was admitted to the emergency department with abdominal pain that lasted for 3 days. She had diabetes mellitus type 2 and had been using metformin 1000 mg once a day for 10 years. She never smoked, had three births, and had no hereditary risk factors for thrombosis. The patient was diagnosed with COVID-19 with a SARS-CoV-2 real-time polymerase chain reaction test and thoracic computed tomography (CT) 25 days ago. In the first CT, ground-glass densities in a consolidated form with common peripheral localization were in line with moderate COVID-19, and the patient had no pathological findings in the abdominal sections (Fig. 1) . She was hospitalized and received therapy of hydroxychloroquine sulfate, piperacillin-tazobactam, clarithromycin, and lowmolecular-weight heparin (LMWH) for 5 days. At her discharge, LMWH treatment was continued with a dose of 6000 IU daily.

Upon hospital admission, she also complained of fever. The temperature was 37°C, respiratory count was 12/min, pulse rate was 88/min, and oxygen saturation was 97% at room air. Physical examination revealed general abdominal tenderness, which was more (Fig. 4a, b, c) .

In Doppler ultrasonography, echogenicity that was consistent with thrombus was detected in PV, SMV, and SV, and no current was observed in the lumen (Fig. 5) . Elevated infectious parameters have led to splenic abscesses secondary to splenic venous thrombosis. As the INR was normal, percutaneous drainage was planned by the interventional radiologist in operating room conditions. Percutaneous drainage was performed for severe fluid collection in the spleen (Fig. 6) , and 1200 mL of infected hemorrhagic fluid was drained by the interventional radiologist. Then, antibiotic therapy (piperacillin + tazobactam) was started, and LMWH at 6000 IU 2×1 treatment dose was administered. The patient's complaints regressed clinically and radiologically on the eighth day, and the patient was discharged with healing ( Fig. 7) .

Many studies had proved that patients with COVID-19 had a risk of thrombotic events. In these patients, hypercoagulability is associated with high D-dimer, fibrinogen, and IL-6 levels, which are also known as poor prognostic factors (4, 5) . In patients with COVID-19, the system affected at the highest level by coagulopathy is the respiratory system, and several studies reported that thrombus occurs in the pulmonary veins (6, 7) . The case presented here is a splenic infarction that developed because of SV thrombosis, which is a rarer form of venous thromboembolism.

Splanchnic venous thrombosis (SVT) refers to thrombosis occurring in the venous circulation that drains the digestive system from the lower end of the esophagus to the upper two-thirds of the rectum (8) . SVT is a rare type of venous thromboembolism, and although its actual incidence is still unknown, it is considered that it develops at a lower rate of at least 25-fold on an annual basis compared to lower extremity deep vein thrombosis and pulmonary embolism (9).

In CT angiography and Doppler ultrasonography of the patient, the presence of portal, superior mesenteric, and SV thrombus was shown. Splenic infarction develops due to SV thrombosis. In this patient, it was considered that two mechanisms might have played roles in the formation of the infarction. The first mechanism is that the infarction developed more likely secondary to the thrombus, which caused obliteration of the SV. The second mechanism is that the spleen could be attacked directly by the SARS-CoV-2 virus, even if there is insufficient evidence. Autopsies conducted on a limited number of patients who died because of COVID-19 showed that the spleen could be attacked directly by the virus, and degeneration and necrosis might develop in cells that can result in changes such as decreases in the T and B lymphocyte count and atrophy in lymphoid follicles (10) .

It is considered that the treatment process was accelerated by the aspiration of a total of 1200 ml hemorrhagic fluid from the patient with percutaneous drainage. No complications developed during the intervention. It is already known that the venous circulation is provided by short gastric and left gastroepiploic veins when the SV is fully obliterated. Moreover, the highly recommended anticoagulant treatment for symptomatic patients with SVT in the current guidelines contributed to the treatment of the patient without splenectomy (11).

As a result, it is important to examine patients who have COVID-19 or are suspected to have it due to nonspecific complaints such as abdominal pain and nausea, considering that thromboembolic events may develop in abdominal vessels. 

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet

Prominent changes in blood coagulation of patients with SARS-CoV-2 infection

Manual of venous and lymphatic diseases

Global burden of thrombosis: epidemiologic aspects

Pathological changes of the spleen in ten patients with new coronavirus infection by minimally invasive autopsies

Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines